Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC)

Revista Espanola de Enfermedades Digestivas

Volumn 105, Issue 2, 2013, Pages 110-112

  Macias García, Fernando ^a,b   Vallejo Senra, Nicolau ^a,b   Baleato González, Sandra ^a   Fernández Castroagudín, Javier ^a,b   Molina Pérez, Esther ^a,b   Enrique Dominguez Munoz J ^a,b  

^a Instituto de Salud Carlos III   (Spain)

^b Foundation for Research in Digestive Diseases (FIENAD)   (Spain)

Author keywords

Ablative percutaneous therapy; Cholangitis; Hepatocellular carcinoma (HCC); Liver; Percutaneous ethanol injection (PEI)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN;

ABDOMINAL PAIN; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; APPENDECTOMY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER RECURRENCE; CAROTID ARTERY DISEASE; CASE REPORT; CHOLANGITIS; CHOLESTASIS; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; DEATH; FEVER; GASTRECTOMY BILLROTH II; HEART MUSCLE ISCHEMIA; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LEUKOCYTE COUNT; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MEDICAL HISTORY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL GASTRECTOMY; PERIPHERAL ISCHEMIA; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; TREATMENT OUTCOME; ABLATION THERAPY; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; FATALITY; INTRALESIONAL DRUG ADMINISTRATION; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROCEDURES;

ABLATION TECHNIQUES; AGED; CARCINOMA, HEPATOCELLULAR; CHOLANGITIS; ETHANOL; FATAL OUTCOME; HUMANS; INJECTIONS, INTRALESIONAL; LIVER ABSCESS; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL;

EID: 84879302619     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082013000200010     Document Type: Note

References (13)

1. Bruix J, Sherman, M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
2. Shibata T, Yamamoto N, Ikai I, Shimahara Y, Yamaoka Y, Itoh K, et al. Choledochojejunostomy: Possible risk factor for septic complications after percutaneous hepatic tumor ablation. AJR Am J Roentgenol 2000;174:985-6.
3. Shibata T, Yamamoto Y, Yamamoto N, Maetani Y, Shibata T, Ikai I, et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol 2003;14:1535-42.
4. Wörns MA, Bosslet T, Victor A, Koch S, Hoppe-Lotichius M, Heise M, et al. Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver. Scand J Gastroenterol 2012;47:718-28.
5. Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis 2010;42:341-7.
6. Castroagudín JF, Delgado M, Villanueva A, Bustamante M, Martínez J, Otero E, et al. Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates. Transplant Proc 2005;37:3871-3.
7. Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 1993;160:1023-8.
8. Kotoh K, Sakai H, Sakamoto S, Nakayama S, Satoh M, Morotomi I, et al. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol 1994;89:194-8.
9. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-8.
10. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-61.
11. Okada S, Aoki K, Okazaki N, Nose H, Yoshimori M, Shimada K, et al. Liver abscess after percutaneous ethanol injection (PEI) therapy for hepatocellular carcinoma: A case report. Hepatogastroenterology 1993;40:496-8.
12. Spies JB, Rosen RJ, Lebowitz AS. Antibiotic prophylaxis in vascular and interventional radiology: a rational approach. Radiology 1988;166: 381-7.
13. Sato S, Mishiro T, Miyake T, Okamoto E, Furuta K, Azumi T, et al. Prophylactic administration of antibiotics unnecessary following ultrasound-guided biopsy and ablation therapy for liver tumors: Openlabeled randomized prospective study. Hepatol Res 2009;39:40-6.